Apimeds

About Apimeds

Apimeds opens up a harmonious future in various fields of business.

Business Field

Apimeds opens up a harmonious future in various fields of business.

Bio Business

We will become a leading company in the bio industry based on our core technology.

SmartGrid Business

With the globalization of Korean PLC, we will take the lead in implementing smart grid systems.

MVNO Business

Provide differentiated services through communication with customers.

Distribution Business

We will make the world shine even more.

Investor Relations

Inscobee leaps forward as a leader in future social change.

About Apimeds

Apimeds opens up a harmonious future in various fields of business.

About INSCOBEE

Inscobee opens up a harmonious future in various fields of business.

History

2020
06	Established the research institute
05	Tested apitoxin for coronavirus and antivirus
05	Established a local corporation in the United States and hired a local CEO

2018
06	Phase 3 clinical research for multiple sclerosis has been approved by the US FDA
04	Completed phase 3 clinical trial for osteoarthritis for the US FDA

2015
07	Submitted a BLA (biologics license application)

2013
05	Registered bee venom medicine in the US Patent and Trademark Office
05	Initiated a phase 3 clinical trial for the US FDA

2012
09	Determined a hospital for a phase 3 clinical trial for the US FDA

2010
07	Launched Apimelina, a new drug for animals
04	Phase 3 clinical trial approved by the US FDA

2009
05	Initiated a phase 2 clinical trial for the US FDA

2008
12	Korean manufacturing plant of ExTT-101, a female medical device, received GMP certification
09	US FDA approved to conduct phase 2 clinical trials
07	Completed a clinical trial of Apimelina, a new drug for animals
06	US clinical trial drug CMC and production completed

2007
07	Registered a patent for apitoxin in Japan

2006
08	Completed apitoxin DMF

2003
09	Established Apimeds Corporation